US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

14.50

+0.62004.47%

Volume:250.52K

Turnover:3.57M

Market Cap:713.67M

PE:-1.27

High:14.66

Open:13.97

Low:13.81

Close:13.88

52wk High:100.10

52wk Low:6.57

Shares:49.22M

Float Shares:33.00M

Volume Ratio:1.14

T/O Rate:0.76%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-11.4494

EPS(LYR):-18.7916

ROE:--

ROA:--

PB:0.25

PE(LYR):-0.77

Loading ...

Overview Company News Filings

Jade Biosciences to Present at Major Healthcare Conferences

Jade Biosciences Initiated at Buy by HC Wainwright & Co.

Jade Biosciences, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $25

THOMSON REUTERS

Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference

Wedbush Adjusts Price Target on Jade Biosciences to $24 From $19, Maintains Outperform Rating

MT Newswires Live

BRIEF-Jade Biosciences Files For Offering Of 3.2 Million Shares Of Common Stock By Selling Stockholder- SEC Filing

Jade Biosciences Files for Offering of 3.2 Mln Shares of Common Stock by Selling Stockholder- SEC Filing

THOMSON REUTERS

BRIEF-Jade Biosciences Announces $45 Million Private Placement

Jade Biosciences Initiated at Buy by Clear Street

Jade Biosciences Files For Offering Of Up To 16.1 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing

Jade Biosciences Is Maintained at Buy by Guggenheim

Jade Biosciences Advances Autoimmune Therapies

BRIEF-Jade Biosciences Files For Offering Of Up To 16.1 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing

Jade Biosciences Inc Files for Offering of up to 16.1 Mln Shares of Common Stock by the Selling Stockholders - SEC Filing

THOMSON REUTERS

Wedbush Adjusts Price Target on Jade Biosciences to $19 From $18, Maintains Outperform Rating

MT Newswires Live

Jade Biosciences Reports Q3 2025 Financial Results

Jade Biosciences: Promising Pipeline and Strategic Expansion Drive Buy Rating

Jade Biosciences Q3 EPS $(0.48) Beats $(0.66) Estimate

Jade Biosciences reports $198.9 million cash position and completes $135 million private placement

Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":14.5,"timestamp":1772053200000,"preClose":13.88,"halted":0,"volume":250520,"delay":0,"changeRate":0.044668587896253546,"floatShares":33002000,"shares":49218491,"eps":-11.4494,"marketStatus":"Pre-Mkt","change":0.62,"latestTime":"02-26 07:45:34 EST","open":13.97,"high":14.66,"low":13.81,"amount":3570142.91174,"amplitude":0.061239,"askPrice":19.07,"askSize":100,"bidPrice":12.11,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-11.4494,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772116200000},"marketStatusCode":1,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":14.5,"postHourTrading":{"tag":"盘后","latestPrice":14.5,"preClose":14.5,"latestTime":"16:04 EST","volume":1745,"amount":25302.5,"timestamp":1772053483679,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1354458168890749,"impliedVol":0.2719,"impliedVolPercentile":0.1088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":33002000,"roa":"--","roe":"--","lyrEps":-18.7916,"volumeRatio":1.1354458168890749,"shares":49218491,"dividePrice":0,"high":14.66,"amplitude":0.061239,"preClose":13.88,"low":13.81,"week52Low":6.565,"pbRate":"0.25","week52High":100.1,"institutionHeld":0,"latestPrice":14.5,"eps":-11.4494,"divideRate":0,"volume":250520,"delay":0,"ttmEps":-11.4494,"open":13.97,"prevYearClose":15.43,"prevWeekClose":14.27,"prevMonthClose":15.61,"prevQuarterClose":15.43,"fiveDayClose":14.46,"twentyDayClose":16.05,"sixtyDayClose":12.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"JBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86},{"date":"2025-04-29","symbol":"JBIO","amount":2.4,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-25","defaultRemindTime":1745933400000,"name":"Jade Biosciences","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-28","payableDate":"2025-04-25","currency":"USD","dateTimestamp":1745899200000,"payDate":"2025-04-28"},{"market":"US","date":"2025-04-29","symbol":"JBIO","defaultRemindTime":1745933400000,"type":"split","dateTimestamp":1745899200000,"forFactor":35,"toFactor":1,"ratio":35},{"market":"US","date":"2025-04-25","symbol":"JBIO","fiscalQuarterEnding":"2025/03","expectedEps":-0.3,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745553600000,"reportTimeType":"post","actualEps":-0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.375,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1768194000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2026-02-25","current":-1.266442,"percent":0.212121,"low":-8.338317,"twenty":-6.89784,"median":-3.262773,"eighty":-2.581925,"high":-2.319279,"avg":-4.328625,"sd":2.047431,"marketCap":638538365},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267},{"date":"2025-08-29","current":-2.805764,"twenty":-3.217485,"median":-2.645214,"eighty":-2.470924,"marketCap":263623978},{"date":"2025-09-05","current":-2.70159,"twenty":-3.17357,"median":-2.64603,"eighty":-2.473669,"marketCap":253835959},{"date":"2025-09-12","current":-2.694645,"twenty":-3.152985,"median":-2.64603,"eighty":-2.4743,"marketCap":253183424},{"date":"2025-09-19","current":-2.677282,"twenty":-3.087798,"median":-2.64603,"eighty":-2.473669,"marketCap":251552088},{"date":"2025-09-26","current":-2.798819,"twenty":-3.080936,"median":-2.64603,"eighty":-2.4743,"marketCap":262971443},{"date":"2025-10-03","current":-2.892576,"twenty":-3.080936,"median":-2.67381,"eighty":-2.479351,"marketCap":271780660},{"date":"2025-10-10","current":-3.264131,"twenty":-3.152985,"median":-2.690514,"eighty":-2.480987,"marketCap":306691262},{"date":"2025-10-17","current":-3.397822,"twenty":-3.16343,"median":-2.70159,"eighty":-2.487393,"marketCap":319252553},{"date":"2025-10-24","current":-3.448173,"twenty":-3.228464,"median":-2.743259,"eighty":-2.487393,"marketCap":323983428},{"date":"2025-10-31","current":-3.420393,"twenty":-3.264131,"median":-2.760622,"eighty":-2.487393,"marketCap":321373290},{"date":"2025-11-07","current":-3.10787,"twenty":-3.295384,"median":-2.802291,"eighty":-2.501116,"marketCap":292009233},{"date":"2025-11-14","current":-3.361361,"twenty":-3.350943,"median":-2.840774,"eighty":-2.504393,"marketCap":315826746},{"date":"2025-11-21","current":-5.620897,"twenty":-3.393147,"median":-2.85789,"eighty":-2.511409,"marketCap":528128273},{"date":"2025-11-28","current":-6.276995,"twenty":-3.403031,"median":-2.873866,"eighty":-2.511409,"marketCap":589773908},{"date":"2025-12-05","current":-6.071353,"twenty":-3.439839,"median":-2.892576,"eighty":-2.514154,"marketCap":570452142},{"date":"2025-12-12","current":-7.266038,"twenty":-3.474564,"median":-2.963052,"eighty":-2.522532,"marketCap":682702402},{"date":"2025-12-19","current":-8.108193,"twenty":-3.595569,"median":-2.993278,"eighty":-2.527742,"marketCap":761829634},{"date":"2025-12-26","current":-8.093505,"twenty":-3.607234,"median":-3.022611,"eighty":-2.532681,"marketCap":760449508},{"date":"2026-01-02","current":-7.554917,"twenty":-3.822008,"median":-3.080936,"eighty":-2.536797,"marketCap":709844883},{"date":"2026-01-09","current":-6.487534,"twenty":-5.801079,"median":-3.116551,"eighty":-2.545612,"marketCap":609555716},{"date":"2026-01-16","current":-7.197491,"twenty":-6.02239,"median":-3.152985,"eighty":-2.555745,"marketCap":676261813},{"date":"2026-01-23","current":-8.333421,"twenty":-6.159485,"median":-3.153012,"eighty":-2.557134,"marketCap":782991569},{"date":"2026-01-30","current":-7.530436,"twenty":-6.394505,"median":-3.1685,"eighty":-2.564099,"marketCap":707544672},{"date":"2026-02-06","current":-7.045707,"twenty":-6.577625,"median":-3.177319,"eighty":-2.571103,"marketCap":662000509},{"date":"2026-02-13","current":-7.251349,"twenty":-6.621691,"median":-3.225463,"eighty":-2.577189,"marketCap":681322276},{"date":"2026-02-20","current":-7.124047,"twenty":-6.808238,"median":-3.251382,"eighty":-2.579625,"marketCap":669361182},{"date":"2026-02-25","current":-6.795998,"twenty":-6.89784,"median":-3.262773,"eighty":-2.581925,"marketCap":638538365}],"updateTime":1772109934595},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610345629","title":"Jade Biosciences to Present at Major Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2610345629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610345629?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:00","pubTimestamp":1770811225,"startTime":"0","endTime":"0","summary":"Jade Biosciences Inc. , a biotechnology company focused on therapies for autoimmune diseases, announced its participation in several upcoming industry conferences. The company will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026, at 1:20 p.m. ET . It will also take part in the TD Cowen 46th Annual Health Care Conference with a presentation and fireside chat on March 2, 2026, at 10:30 a.m. ET. Additionally, Jade will participate in a fireside chat at the Leerink Global Healthcare Conference on March 11, 2026, at 8:40 a.m. ET, and will host one-on-one investor meetings at the Jefferies Biotech on the Beach Summit from March 10-11, 2026. A live webcast of the presentations will be available on the Events & Presentations page of the Jade Biosciences website, with archived replays accessible for 90 days following each event.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL9B77z4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4539","BK4139","BK4112","NDAQ","JBIO","SG9999014005.SGD","LU2210149790.SGD","LU0314104364.USD","SG9999014039.USD","LU2095319765.USD","BK4585","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014021.USD"],"gpt_icon":0},{"id":"2601877142","title":"Jade Biosciences Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2601877142","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601877142?lang=en_us&edition=fundamental","pubTime":"2026-01-07 19:49","pubTimestamp":1767786540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 07, 2026 06:49 ET (11:49 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"gpt_icon":0},{"id":"2601872378","title":"Jade Biosciences, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating  and Target Price $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2601872378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601872378?lang=en_us&edition=fundamental","pubTime":"2026-01-07 19:08","pubTimestamp":1767784112,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nAZN4RRZXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","JBIO"],"gpt_icon":0},{"id":"2601886637","title":"Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601886637","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601886637?lang=en_us&edition=fundamental","pubTime":"2026-01-05 20:00","pubTimestamp":1767614400,"startTime":"0","endTime":"0","summary":"JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026Phase 2 clinical trial of JADE101 in patients with IgA nephropathy expected to begin mid-","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/05/3212593/0/en/Jade-Biosciences-Outlines-Key-2026-Objectives-and-Strategy-to-Advance-Pipeline-of-Potentially-Best-in-Class-Monoclonal-Antibodies-Across-Multiple-Autoimmune-Diseases-Ahead-of-the-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU1989772840.SGD","LU1548497426.USD","LU1363072403.SGD","LU1162221912.USD","LU0158827948.USD","LU1668664300.SGD","LU1791710400.SGD","LU0098860793.USD","BK4137","LU0158827781.USD","IE00BKVL7J92.USD","LU2111349929.HKD","LU0267386448.USD","LU0557290698.USD","JBIO","LU1244550221.USD","BK4581","HCSG","LU0006306889.USD","LABU","BK4539","LU1732800096.USD","LU2089284900.SGD","LU1989772923.USD","LU0971096721.USD","XBI","BK4516","LU0528227936.USD","LU2357305700.SGD","BK4534","LU2023251221.USD","LU0795875169.SGD","LU2089283258.USD","LU2133065610.SGD","XLV","LU0106261372.USD","LU2028103732.USD","LU2271345857.HKD","LU0912757837.SGD","BK4139","BK4127","BK4588","LU1720051108.HKD","LU1732799900.SGD","BK4504","LU0106831901.USD","LU0128526141.USD","LU2347655156.SGD","LU1720051017.SGD"],"gpt_icon":0},{"id":"2593818410","title":"Wedbush Adjusts Price Target on Jade Biosciences to $24 From $19, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2593818410","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593818410?lang=en_us&edition=fundamental","pubTime":"2025-12-24 03:23","pubTimestamp":1766517796,"startTime":"0","endTime":"0","summary":"Price: 16.20, Change: -0.67, Percent Change: -3.97","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO"],"gpt_icon":0},{"id":"2593455700","title":"BRIEF-Jade Biosciences Files For Offering Of 3.2 Million Shares Of Common Stock By Selling Stockholder- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2593455700","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593455700?lang=en_us&edition=fundamental","pubTime":"2025-12-23 06:54","pubTimestamp":1766444064,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Files For Offering Of 3.2 Million Shares Of Common Stock By Selling Stockholder- SEC FilingDec 22  - Jade Biosciences Inc JBIO.O:JADE BIOSCIENCES FILES FOR OFFERING OF 3.2 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDER- SEC FILINGSource text: [ID:n0001193125-25-328848]Further company coverage: JBIO.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS0AG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4539","BK4139"],"gpt_icon":0},{"id":"2593327453","title":"Jade Biosciences Files for Offering of 3.2 Mln Shares of Common Stock by Selling Stockholder- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2593327453","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593327453?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:40","pubTimestamp":1766439607,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS0AG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","JBIO"],"gpt_icon":0},{"id":"2591645455","title":"BRIEF-Jade Biosciences Announces $45 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2591645455","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591645455?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:10","pubTimestamp":1765800633,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Announces $45 Million Private PlacementDec 15 (Reuters) - Jade Biosciences Inc JBIO.O:JADE BIOSCIENCES ANNOUNCES $45 MILLION PRIVATE PLACEMENTSource text: ID:nGNX6CVfmkFurther company coverage: JBIO.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA6GGKCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JBIO","BK4139"],"gpt_icon":0},{"id":"2586943478","title":"Jade Biosciences Initiated at Buy by Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2586943478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586943478?lang=en_us&edition=fundamental","pubTime":"2025-11-25 20:37","pubTimestamp":1764074220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2025 07:37 ET (12:37 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","JBIO"],"gpt_icon":0},{"id":"2584212922","title":"Jade Biosciences Files For Offering Of Up To 16.1 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584212922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584212922?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:48","pubTimestamp":1763574516,"startTime":"0","endTime":"0","summary":"Nov 14 (Reuters) - Jade Biosciences Inc ::*JADE BIOSCIENCES INC FILES FOR OFFERING OF UP TO 16.1 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 14-NOV-202521:17:12 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD6BvStn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","JBIO"],"gpt_icon":0},{"id":"2584558089","title":"Jade Biosciences Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2584558089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584558089?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:23","pubTimestamp":1763475780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 18, 2025 09:23 ET (14:23 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"gpt_icon":0},{"id":"2583631886","title":"Jade Biosciences Advances Autoimmune Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2583631886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583631886?lang=en_us&edition=fundamental","pubTime":"2025-11-15 12:15","pubTimestamp":1763180128,"startTime":"0","endTime":"0","summary":"Jade Biosciences, Inc. ( ($JBIO) ) has released its Q3 earnings. Here is a breakdown of the information Jade Biosciences, Inc. presented to its inv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-advances-autoimmune-therapies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-advances-autoimmune-therapies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","JBIO"],"gpt_icon":0},{"id":"2583599684","title":"BRIEF-Jade Biosciences Files For Offering Of Up To 16.1 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2583599684","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583599684?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:17","pubTimestamp":1763155032,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Files For Offering Of Up To 16.1 Million Shares Of Common Stock By The Selling Stockholders - SEC FilingNov 14  - Jade Biosciences Inc JBIO.O:JADE BIOSCIENCES INC FILES FOR OFFERING OF UP TO 16.1 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILINGSource text: [ID:n0001193125-25-282921]Further company coverage: JBIO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WQ1HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JBIO"],"gpt_icon":0},{"id":"2583843696","title":"Jade Biosciences Inc Files for Offering of up to 16.1 Mln Shares of Common Stock by the Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2583843696","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583843696?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:15","pubTimestamp":1763154937,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WQ1HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","JBIO","BK4139"],"gpt_icon":0},{"id":"2583504507","title":"Wedbush Adjusts Price Target on Jade Biosciences to $19 From $18, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2583504507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583504507?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:17","pubTimestamp":1763129877,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) has an average rating of buy and mean price target of $19, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO"],"gpt_icon":0},{"id":"2583505445","title":"Jade Biosciences Reports Q3 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505445","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583505445?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:31","pubTimestamp":1763123483,"startTime":"0","endTime":"0","summary":"Jade Biosciences ( ($JBIO) ) just unveiled an announcement. On April 28, 2025, Jade Biosciences, formerly Aerovate Therapeutics, completed a busine...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-reports-q3-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-reports-q3-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","JBIO"],"gpt_icon":0},{"id":"2583545856","title":"Jade Biosciences: Promising Pipeline and Strategic Expansion Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2583545856","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583545856?lang=en_us&edition=fundamental","pubTime":"2025-11-14 07:35","pubTimestamp":1763076926,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren has maintained their bullish stance on JBIO stock, giving a Buy rating on November 3. Tyler Van Buren has given hi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/jade-biosciences-promising-pipeline-and-strategic-expansion-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/jade-biosciences-promising-pipeline-and-strategic-expansion-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"gpt_icon":0},{"id":"2583512260","title":"Jade Biosciences Q3 EPS $(0.48) Beats $(0.66) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512260","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512260?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:33","pubTimestamp":1763069632,"startTime":"0","endTime":"0","summary":"Jade Biosciences (NASDAQ:JBIO) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.66) by 27.27 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48851453/jade-biosciences-q3-eps-0-48-beats-0-66-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Jade Biosciences Q3 EPS $(0.48) Beats $(0.66) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"gpt_icon":0},{"id":"2583151433","title":"Jade Biosciences reports $198.9 million cash position and completes $135 million private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2583151433","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583151433?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:06","pubTimestamp":1763067979,"startTime":"0","endTime":"0","summary":"Jade Biosciences Inc. reported cash, cash equivalents, and investments of $198.9 million as of September 30, 2025. Following the completion of a $135.0 million private placement in October, the company's cash position increased to approximately $325.6 million on a pro-forma basis as of September 30, 2025. Jade stated that its current cash is expected to fund operating expenses and capital expenditure requirements into the first half of 2028. During the period, Jade presented preclinical safety and biomarker data for JADE101, initiated a Phase 1 healthy volunteer study of JADE101, and introduced JADE201, with a first-in-human trial in rheumatoid arthritis planned for the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDLPhkFn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","BK4139","BK4588","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4585","NDAQ","BK4539","JBIO","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2583514981","title":"Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583514981","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583514981?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067900,"startTime":"0","endTime":"0","summary":"Presented favorable preclinical safety data for JADE101 and a translational analysis of APRIL mediated biomarker responses at the American Society of Nephrology Kidney Week 2025, reinforcing its poten","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187849/0/en/Jade-Biosciences-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JBIO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}